JMI LABS IS NOW PART OF LEARN MORE

Activity of Oritavancin Tested Against Contemporary Gram-Positive Pathogens Submitted to a Global Surveillance Program (2008), Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

View publication